| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $81.0M | +105.6% |
| R&D Expense | $15.7M | +150.1% |
| SG&A Expense | $37.1M | +156.0% |
| Operating Income | -$135.5M | -280.2% |
| Income Tax | -$215K | +0.0% |
| Net Income | -$116.4M | -920.9% |
| EPS (Basic) | -$0.58 | -1060.0% |
| EPS (Diluted) | -$0.58 | -1060.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $218.3M | -35.2% |
| Short-term Investments | $1.1M | +3.2% |
| Accounts Receivable | $5.4M | +14.6% |
| Current Assets | $238.0M | -32.5% |
| Total Assets | $295.7M | -19.4% |
| Current Liabilities | $33.6M | +110.4% |
| Total Liabilities | $44.1M | +61.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$92.9M | -187.4% |
| Capital Expenditures | $14.6M | +70.6% |
| Investing Cash Flow | -$23.8M | -134.5% |
| Financing Cash Flow | -$2.1M | -100.6% |
| Free Cash Flow | -$107.5M | -163.0% |
| Stockholders' Equity |
| $251.6M |
| -25.9% |